Ribulose-5-phosphate-3-epimerase pseudogene 6 (RPEP6)

RPEP6 refers to a pseudogene in the human genome named "ribulose-5-phosphate-3-epimerase pseudogene 6." Pseudogenes are non-functional segments of DNA that resemble functional genes but do not encode an active protein product[3][1]. They are typically formed via duplication, retrotransposition, or mutation of ancestral protein-coding genes[1][3]. RPEP6 is presumably a processed pseudogene: this means it originated from reverse transcription of an mRNA, giving rise to a DNA segment lacking native regulatory elements and usually unable to be transcribed or translated into a functional enzyme[3][1]. The parent, ribulose-5-phosphate-3-epimerase (EC 5.1.3.1), is an enzyme involved in carbon metabolism pathways including the Calvin cycle and the pentose phosphate pathway; it catalyzes the interconversion of ribulose-5-phosphate and xylulose-5-phosphate[2][4]. However, RPEP6 itself is not known to encode functional protein, does not act as an enzyme, and would not be considered a druggable target or therapeutic receptor[3][1]. There is no evidence in available literature indicating that RPEP6 has established biological functions, roles in disease, or interactions with drugs. Summary of limitations: RPEP6 is a pseudogene, not a canonical therapeutic target, receptor, enzyme, or drug target. No biomarker, safety, or pharmacological data are associated. Any query referring to RPEP6 as an active molecule is incorrect.

Other names

RPEP6